These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38371620)

  • 1. Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy.
    Marino G; Grassi T; De Ponti E; Negri S; Testa F; Giuliani D; Delle Marchette M; Dell'Oro C; Fumagalli D; Donatiello G; Besana G; Marchetta L; Bonazzi CM; Lissoni AA; Landoni F; Fruscio R
    Front Oncol; 2024; 14():1330481. PubMed ID: 38371620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
    Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
    Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis.
    Bergamini A; Sarwar N; Ferrandina G; Scarfone G; Short D; Aguiar X; Camnasio C; Kaur B; Savage PM; Cormio G; Lim A; Pignata S; Mangili G; Seckl MJ
    Eur J Cancer; 2020 Sep; 137():136-143. PubMed ID: 32763784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early stage ovarian immature teratoma, surveillance or chemotherapy after surgery? A propensity score matched analysis.
    Zhang X; Yang J; Wang J; Zhang Y; Yang J
    Gynecol Oncol Rep; 2022 Apr; 40():100976. PubMed ID: 35434235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility outcomes in stage I ovarian immature teratomas.
    Marino G; Grassi T; De Ponti E; Testa F; Negri S; Giuliani D; Seca M; Bombelli M; Santagati A; Bertoni M; Jaconi M; Bonazzi CM; Lissoni AA; Landoni F; Fruscio R
    Int J Gynecol Cancer; 2024 Sep; 34(9):1416-1422. PubMed ID: 39222973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic comparison of active surveillance and adjuvant chemotherapy in the treatment of patients with stage Ⅰ ovarian immature teratoma after fertility-sparing surgery].
    Zhang XY; Yang J; Xiang Y; Wu M; Pan LY; Yang JX
    Zhonghua Fu Chan Ke Za Zhi; 2023 Nov; 58(11):838-845. PubMed ID: 37981770
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
    Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
    Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases.
    Li S; Zhang X; Zhang T; Yin M; Cao D; Xiang Y; Yang J
    Ann Med; 2023; 55(2):2273984. PubMed ID: 37909181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study.
    Mangili G; Giorda G; Ferrandina G; Cormio G; Cassani C; Savarese A; Danese S; Carnelli M; Vasta FM; Perrone AM; Scarfone G; Pignata S; Legge F; Raspagliesi F; Taccagni G; Candiani M; Bogani G; Mascilini F; Bergamini A
    Int J Gynecol Cancer; 2021 Sep; 31(9):1242-1247. PubMed ID: 34035080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative.
    Pashankar F; Hale JP; Dang H; Krailo M; Brady WE; Rodriguez-Galindo C; Nicholson JC; Murray MJ; Bilmire DF; Stoneham S; Arul GS; Olson TA; Stark D; Shaikh F; Amatruda JF; Covens A; Gershenson DM; Frazier AL
    Cancer; 2016 Jan; 122(2):230-7. PubMed ID: 26485622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility sparing approach as the standard of care in young patients with immature teratomas.
    Iavazzo C; Vorgias G; Iavazzo PE; Gkegkes ID
    J Turk Ger Gynecol Assoc; 2017 Mar; 18(1):43-47. PubMed ID: 28506950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).
    Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D
    Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Adjuvant Chemotherapy in Stage I Pure Ovarian Immature Teratoma: A Systematic Review and Meta-Analysis.
    Li S; Wang Y; Zhang X; Zhang T; Yin M; Yang J
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure pediatric ovarian immature teratomas: The French experience.
    Pavone R; Dijoud F; Galmiche L; Ro V; Hameury F; Sarnacki S; Orbach D; Briandet C; Pasquet M; Bertrand A; Fresneau B; Faure-Conter C
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28186. PubMed ID: 31981415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM
    Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
    Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A
    World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric ovarian immature teratoma: Histological grading and clinical characteristics.
    Shinkai T; Masumoto K; Chiba F; Shirane K; Tanaka Y; Aiyoshi T; Sasaki T; Ono K; Gotoh C; Urita Y; Takayasu H; Suzuki R; Sakashita S
    J Pediatr Surg; 2020 Apr; 55(4):707-710. PubMed ID: 31130350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites.
    Patterson DM; Murugaesu N; Holden L; Seckl MJ; Rustin GJ
    Int J Gynecol Cancer; 2008; 18(1):43-50. PubMed ID: 17466047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mature and immature teratoma: A report from the second Italian pediatric study.
    Terenziani M; D'Angelo P; Inserra A; Boldrini R; Bisogno G; Babbo GL; Conte M; Dall' Igna P; De Pasquale MD; Indolfi P; Piva L; Riccipetitoni G; Siracusa F; Spreafico F; Tamaro P; Cecchetto G
    Pediatr Blood Cancer; 2015 Jul; 62(7):1202-8. PubMed ID: 25631333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratomas in infancy and childhood.
    Göbel U; Calaminus G; Engert J; Kaatsch P; Gadner H; Bökkerink JP; Hass RJ; Waag K; Blohm ME; Dippert S; Teske C; Harms D
    Med Pediatr Oncol; 1998 Jul; 31(1):8-15. PubMed ID: 9607423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.